Vertex Pharmaceuticals
VRTX
#137
Rank
S$163.22 B
Marketcap
$633.81
Share price
0.25%
Change (1 day)
17.48%
Change (1 year)

Earnings for Vertex Pharmaceuticals (VRTX)

Earnings in 2024 (TTM): S$0.25 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's current earnings are S$10.62 Billion. In 2023 the company made an earning of S$5.97 Billion, an increase over its 2022 earnings that were of S$5.79 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vertex Pharmaceuticals from 1990 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) S$0.25 B-95.65%
2023 S$5.97 B3.19%
2022 S$5.79 B53.56%
2021 S$3.77 B-12.06%
2020 S$4.28 B118.45%
2019 S$1.96 B120.64%
2018 S$0.88 B1473.64%
2017 S$56.54 M197.6%
2016 S$18.99 M-102.97%
2015 -S$0.64 Billion-28.46%
2014 -S$0.9 Billion-51.5%
2013 -S$1.85 Billion-30584.68%
2012 S$6.04 M-95.47%
2011 S$0.13 B
2009 -S$0.81 Billion
2007 -S$0.56 Billion83.1%
2006 -S$0.31 Billion59.02%
2005 -S$0.2 Billion3.28%
2004 -S$0.19 Billion-38.16%
2003 -S$0.3 Billion
2000 -S$51.39 Million-20.38%
1999 -S$64.54 Million31.62%
1998 -S$49.04 Million91.05%
1997 -S$25.67 Million-36.24%
1996 -S$40.26 Million12.45%
1995 -S$35.8 Million27.4%
1994 -S$28.1 Million-1833.33%
1993 S$1.62 M-112.12%
1992 -S$13.38 Million175%
1991 -S$4.87 Million-12.2%
1990 -S$5.54 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
S$0.23 B-40.94%๐Ÿ‡บ๐Ÿ‡ธ USA
S$9.72 B 2,315.10%๐Ÿ‡บ๐Ÿ‡ธ USA
S$20.22 B 4,924.50%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$9.3 Billion-2,408.72%๐Ÿ‡บ๐Ÿ‡ธ USA
S$24.84 B 6,072.82%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.15 Billion-135.86%๐Ÿ‡บ๐Ÿ‡ธ USA